BP
Balaji Prasad Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
9.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
0%
Negative
14.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Pharmaceutical Retailers
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $25 |
342%
upside
| 2 | -30% |
0
%
| 5 Mar ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $11 |
15%
downside
| 1 | +49% |
0
%
| 3 Mar ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $24 |
2%
upside
| 1 | -7.3% |
0
%
| 28 Feb ‘25 10 months ago |
|
|
|
Underweight
Maintained
| $9 |
29%
downside
| 1 | -34% |
0
%
| 28 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $200 |
24%
upside
| 1 | +12% |
0
%
| 27 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $19 |
19%
downside
| 1 | +119% |
0
%
| 26 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $60 |
22%
downside
| 2 | +35% |
0
%
| 26 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $244 |
92%
upside
| 1 | -23% |
0
%
| 14 Feb ‘25 11 months ago |
|
|
|
Overweight
Maintained
| $24 |
198%
upside
| 1 | -51% |
0
%
| 14 Feb ‘25 11 months ago |
|
|
|
Underweight
Maintained
| $22 |
44%
downside
| 1 | -66% |
0
%
| 10 Feb ‘25 11 months ago |
|
|
|
Overweight
Maintained
| $520 |
27%
downside
| 1 | +52% |
0
%
| 4 Feb ‘25 11 months ago |
|
|
|
Overweight
Maintained
| $26 |
19%
downside
| 1 | +73% |
0
%
| 30 Jan ‘25 11 months ago |
|